We are excited to share that EUR 10 million has been awarded to NecstGen, NTrans Technologies BV, Leiden University Medical Center, and Divvly to transform Cell and Gene Therapies through the IPCEI Med4Health program. This significant funding will drive our efforts to transform the production of cell and gene therapies, making these life-saving treatments more accessible and affordable for patients in need.